EHRA Premium Access

Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Congress Session

About the speaker

Doctor William Mcintyre

McMaster University, Hamilton (Canada)
0 follower

5 more presentations in this session

Diabetes mellitus, time in the therapeutic range and adverse outcomes in patients with atrial fibrillation: insights from the AFFIRM study

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

Different obesity paradox of ischemic stroke without and with atrial fibrillation

Speaker: Assistant Professor Y. Baek (Incheon, KR)

Thumbnail

Usefulness of CHADS2-VASc score in predicting stroke in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Doctor A. Berkovitch (Tel Hashomer, IL)

Thumbnail

Prediction of Thromboembolic Events in Anticoagulated Patients with Atrial Fibrillation: Comparison of CHA2DS2-VASc and GARFIELD-AF Stroke Risk Scores

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure

Speaker: Doctor S. Bordignon (Frankfurt, DE)

Thumbnail

Access the full session

Moderated ePosters 11: AF: stroke and anticoagulation

Speakers: Doctor W. Mcintyre, Doctor M. Proietti, Assistant Professor Y. Baek, Doctor A. Berkovitch, Doctor M. Proietti...
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk